UK medical cannabis clinic Releaf has launched a new 24/7 on-demand legal support service for its prescribed patients, helping navigate common issues with their medication with professional guidance.
The second in our series of guest episodes features a discussion between CEO of Releaf, Tim Kirby, and James Duckenfield, CEO of Glass Pharms.
Creating a culture that focuses on the behaviours required to achieve the results desired, has been the root cause of Releaf’s success in the UK’s medical cannabis sector – a sector that has stagnated since medical cannabis became legal in 2018.
Since the UK legalisation of CBPMs in 2018, the sector has faced slow adoption due to ineffective patient outreach, inconsistent supply chains and variable quality control from other providers.
